✦ LIBER ✦

43 LONG TERM TENOFOVIR DISOPROXIL FUMARATE (TDF) THERAPY AND THE RISK OF HEPATOCELLULAR CARCINOMA

✍ Scribed by Kim, W.R.; Berg, T.; Loomba, R.; Schall, R. Aguilar; Dinh, P.; Yee, L.J.; Martins, E.B.; Flaherty, J.F.; Gurel, S.; Buti, M.; Marcellin, P.

Book ID: 122754338
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 113 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(13)60045-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of hypophosphataemia in tenof

Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy

✍ K Buchacz; JT Brooks; T Tong; AC Moorman; RK Baker; SD Holmberg; A Greenberg; th 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Long-term interferon monotherapy reduces

Long-term interferon monotherapy reduces the risk of HCV-associated hepatocellular carcinoma

✍ Makiko Takeyasu; Norio Akuta; Fumitaka Suzuki; Yuya Seko; Yusuke Kawamura; Hitom 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

Risk assessment for the development of h

Risk assessment for the development of hepatocellular carcinoma: According to on-treatment viral response during long-term lamivudine therapy in hepatitis B virus-related liver disease

✍ Jong Ryul Eun; Heon Ju Lee; Tae Nyeun Kim; Kyeung Soo Lee 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 626 KB

1019 GENETIC POLYMORPHISM ASSOCIATED WIT

1019 GENETIC POLYMORPHISM ASSOCIATED WITH POOR LONG-TERM OUTCOME OF HEPATOCELLULAR CARCINOMA PATIENTS FOLLOWING THE COMBINED THERAPY WITH TRANSARTERIAL CHEMOEMBOLIZATION AND SORAFENIB

✍ Lee, J.-H.; Chung, Y.-H.; Kim, J.A.; Shin, E.-S.; Lee, D.; Shim, J.H.; Lee, H.C. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Multimodal image-guided tailored therapy

Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: Long-term survival in the experience of a single radiologic referral center

✍ Tito Livraghi; Franca Meloni; Alberto Morabito; Claudio Vettori 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 453 KB 👁 1 views

The best treatment policy for some patients with hepatocellular carcinoma (HCC) and compensated cirrhosis is still controversial. The aim of this study was to evaluate the long-term survival and related prognostic factors of patients with early and intermediate HCC (Liver Unit of Barcelona classific

Acute renal failure after transarterial

Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome

✍ T.-I. Huo; J.-C. Wu; Y.-H. Huang; J.-H. Chiang; P.-C. Lee; F.-Y. Chang; S.-D. Le 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB